Status:
COMPLETED
Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
SMG-SNU Boramae Medical Center
Conditions:
Thyroid Diseases
Surgical Injury
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
For successful intraoperative neuromonitoring (IONM), adequate reversal of neuromuscular blocking agent is a prerequisite in thyroid surgery with . The aim of this study is to investigate the feasibi...
Detailed Description
For successful intraoperative neuromonitoring (IONM), adequate reversal of neuromuscular blocking agent is a prerequisite in thyroid surgery with . The aim of this study is to investigate the feasibi...
Eligibility Criteria
Inclusion
- open thyroid surgery with intraoperative neuromonitoring
Exclusion
- refusal to participate in the study
- rocuronium should not be used (e.g. renal dysfunction patient)
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04873531
Start Date
May 10 2021
End Date
August 31 2021
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Seoul, South Korea, 07061